Advanced Discovery Research, LLC. | Atlanta, GA

Research site

(Unclaimed)

Location

652 Bellemeade Avenue NW, Atlanta, Georgia, United States of America

Site insights

Top conditions

Top treatments

SEP-363856

BI 1358894

SLS-002

Fluoxetine

Azetukalner

HCl

BMS-986368

JZP150

SPN-812

Quetiapine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 17 total trials

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA2)

X-NOVA2 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of...

Enrolling

Major Depressive Disorder

Drug: Placebo

Drug: Azetukalner

A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder

Demonstrate ability of SEP-363856 to be superior to placebo as an adjunctive therapy to ADT in change from baseline in depressive symptoms (MADRS \&...

Active, not recruiting

Major Depressive Disorder

Other: Placebo

Drug: SEP-363856

Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine

This is a Phase 2 randomized, double-blinded, placebo-controlled study that will evaluate multiple potential pharmacotherapeutic interventions for PT...

Enrolling

Post Traumatic Stress Disorder

Drug: Intervention A Fluoxetine Hydrochloride (HCl)

Drug: Intervention A Placebo

Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant

This is a Phase 2 randomized, double-blinded, placebo-controlled study that will evaluate multiple potential pharmacotherapeutic interventions for PT...

Enrolling

Post Traumatic Stress Disorder

Drug: Intervention C Placebo

Drug: Intervention C Daridorexant

Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002

This is a Phase 2 randomized, double-blinded, placebo-controlled study that will evaluate multiple potential pharmacotherapeutic interventions for Po...

Not yet enrolling

Post Traumatic Stress Disorder

Drug: Intervention D Placebo

Drug: Intervention D SLS-002

Department of Defense PTSD Adaptive Platform Trial - Master Protocol

This is a Phase 2 randomized, double-blinded, placebo-controlled study that will evaluate multiple potential pharmacotherapeutic interventions for PT...

Enrolling

Post Traumatic Stress Disorder

Drug: Intervention C Placebo

Drug: Intervention D Placebo

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

This study will evaluate the efficacy and safety of SPN-812 (viloxazine extended release) in children 4 to 5 years of age with ADHD.

Enrolling

Attention-Deficit/Hyperactivity Disorder

Drug: Placebo

Drug: 100mg SPN-812

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

The purpose of this study is to know how well seltorexant works, and also to evaluate safety and maintenance effect of seltorexant compared with plac...

Enrolling

Depressive Disorder, Major

Drug: Selective Serotonin Reuptake Inhibitor (SSRI)/Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)

Drug: Placebo

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

This is a study to evaluate the efficacy, safety, and tolerability of BMS-986368, a FAAH/MAGL inhibitor, for the treatment of agitation in participan...

Enrolling

Alzheimer Disease

Agitation

Drug: Placebo

Drug: BMS-986368